FDA Pre-Approval Of Commercial Speech: “Coming Soon” To DTC Device Ads?

AdvaMed is urging FDA to consider a pre-approval policy for direct-to-consumer advertising within the Center for Devices & Radiological Health

More from Archive

More from Medtech Insight